
Number of cases opened by FDA's Office of Criminal Investigations (OCI) triples to 170

'Scriptbags' and 'Rep in a Box' are about to be tested in pharma sample distribution

Data compiled by the Worldwide Network for Blood and Marrow Transplantation (WNBMT) measures the landmark; some 70 diseases are now treated by the therapy

Branded as Orca 2.0, the line features advanced phase-change material and proprietary software design

New emphasis will be placed on last-mile courier holdups

Arrangement expands Cryoport's service agreement with the lab

Arrangement expands Cryoport's service agreement with the lab

While the 'agg spend' rules sit in the Office of Management and Budget, healthcare advocacy groups fume

Optum Labs will run analytics on millions of claims and clinical records to find improved outcomes

While regulators were worried about the European market, deal would have also shifted the emerging-markets competitive scene

NYPD Commissioner Raymond Kelly sketches out GPS tracking decoys for controlled substances

Annual competition promotes the use of compliance packaging to improve medication adherence and safety

Distributors, retail pharmacy and others pile into the specialty-pharma services

Proportion of cold chain products continues to grow in the biopharma inventory

Proportion of cold chain products continues to grow in the biopharma inventory

MTS' Credo brand now becomes a Pelican property

Annual Tompkins Global Trade Management Report surveys industry practices

Companies facing fewer funding sources, reimbursement issues

Agency is trying to quantify the effects of abuse-deterrent formulations

Structure provides a global network to standardize media strategy, buying and digital-search services

Step is one of the first toward consolidation of electronic health providers and information publishers

Hangzhou, Shanghai and Sydney bring 325,000 sq. ft. of dedicated space to market

Lack of quantitative clinical results and FDA regulatory uncertainty leave unclear benefits for this $300-billion problem

Distinguishing between pharmaceutical manufacturing and pharmacy compounding remains a policy conflict

PwC's annual analysis sees bright spots in R&D practices, while global economic troubles will constrain healthcare spending

Peer-reviewed study correlates adverse drug events (ADEs) with form of drug administration; can pharma manufacturers help?

Implementation of the Physicians Sunshine Act may require you to begin data gathering by Feb. 25, but questions remain over the law's details, from data to dollars

Financial-services firm's index of biotech stocks rose 40.5% in 2012; predicts a better year for financings and M&A activity in 2013

New report assesses the progress in adopting both of these marketing techniques

Patent-pending technology provides an 'e-fingerprint' to go with barcode data; data can be retrieved from a cloud-based repository